Karo Pharma AB buy Morgan Stanley
Start price
31.07.23
/
50%
€5.44
Target price
31.07.24
€30.83
Performance (%)
-
End price
01.08.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karo Pharma AB | - | - | - |
| iShares Core DAX® | -0.168% | 4.802% | 17.488% |
| iShares Nasdaq 100 | 2.946% | 3.520% | 23.619% |
| iShares Nikkei 225® | 1.319% | 6.746% | 12.949% |
| iShares S&P 500 | 2.044% | 3.551% | 23.055% |
Comments by Morgan_Stanley for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten